Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Trigeminal Neuralgia Treatment Market Portraiture
2.2 Global Trigeminal Neuralgia Treatment Market, by Treatment, 2016 (US$ Mn)
2.3 Global Trigeminal Neuralgia Treatment Market, by Geography, 2016 (Value %)
Chapter 3 Global Trigeminal Neuralgia Treatment Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Growing prevalence of chronic pain disorders have generated demand for Trigeminal Neuralgia Treatment
3.2.2 Rise in aging population and public awareness have generated demand for Trigeminal Neuralgia Treatment
3.3 Market Restraints
3.3.1 Insufficient funding in emerging markets and high cost involved in treatment of Trigeminal Neuralgia
3.4 Market Opportunities
3.4.1 Improved Healthcare expenditure due to patient oriented reimbursement policies and tapping market of unmet medical needs
3.5 Porter’s Five Forces Model
3.6 Attractive Investment Proposition
3.7 Market Competition Assessment: Trigeminal Neuralgia Treatment, by Key Players
Chapter 4 Global Trigeminal Neuralgia Treatment Market, By Type of Treatment
4.1 Introduction
4.2 Drug Based
4.2.1 Anticonvulsant
4.2.2 NSAIDs
4.2.3 Opioids
4.3 Surgery
4.3.1 Rhizotomy
4.3.2 Stereotactic radiosurgery
4.3.3 Micro vascular decompression
Chapter 5 Global Trigeminal Neuralgia Treatment Market, By Geography
5.1 Preface
5.2 North America
5.3 Europe
5.4 Asia Pacific
5.5 Latin America
5.6 Middle East and Africa
Chapter 6 Company Profiles
6.1 Allergan Plc
6.1.1 Allergan Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.2 Biogen, Inc.
6.2.1 Biogen, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.3 Kineta Inc.
6.3.1 Kineta Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.4 Merz Pharma GmbH & Co.
6.4.1 Merz Pharma GmbH & Co.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.5 Trigemina Inc.
6.5.1 Trigemina Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.6 Abbott Laboratories
6.6.1 Abbott Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.7 Pfizer Inc.
6.7.1 Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.8 GlaxoSmithKline Plc.
6.8.1 GlaxoSmithKline Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.9 Novartis
6.9.1 Novartis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.10 Shire
6.10.1 Shire: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
List of Figures
FIG. 1 Trigeminal Neuralgia Treatment Market: Research Methodology
FIG. 2 Global Trigeminal Neuralgia Treatment Market, by Treatment 2016 (US$ Mn)
FIG. 3 Global Trigeminal Neuralgia Treatment Market, by Geography, 2016 (Value %)
FIG. 4 Porter’s Five Forces Model: Trigeminal Neuralgia Treatment Market
FIG. 5 Attractive Investment Proposition, by Geography,2016
FIG. 6 Market Positioning of Key Trigeminal Neuralgia Treatment Market Players, 2016
FIG. 7 Anticonvulsant Market for Trigeminal Neuralgia Treatment, 2015 – 2025 (US$ Mn)
FIG. 8 NSAIDs Market for Trigeminal Neuralgia Treatment, 2015 – 2025 (US$ Mn)
FIG. 9 Opioids Market for Trigeminal Neuralgia Treatment, 2015 – 2025 (US$ Mn)
FIG. 10 Rhizotomy Market for Trigeminal Neuralgia Treatment, 2015 – 2025 (US$ Mn)
FIG. 11 Rhizotomy Market for Trigeminal Neuralgia Treatment, 2015 – 2025 (US$ Mn)
FIG. 12 Rhizotomy Market for Trigeminal Neuralgia Treatment, 2015 – 2025 (US$ Mn)
FIG. 13 North America Trigeminal Neuralgia Treatment Market , 2015 – 2025 (US$ Mn)
FIG. 14 Europe Trigeminal Neuralgia Treatment Market , 2015 – 2025 (US$ Mn)
FIG. 15 Asia-Pacific Trigeminal Neuralgia Treatment Market , 2015 – 2025 (US$ Mn)
FIG. 16 Latin America Trigeminal Neuralgia Treatment Market , 2015 – 2025 (US$ Mn)
FIG. 17 Middle East and Africa Trigeminal Neuralgia Treatment Market , 2015 – 2025 (US$ Mn)
List of Tables
TABLE 1 Global Trigeminal Neuralgia Treatment Market, By Treatment, 2015-2025 (US$ Mn)
TABLE 2 Drug based treatment market for Trigeminal Neuralgia, 2015-2025 (US$ Mn)
TABLE 3 Surgery based treatment market for Trigeminal Neuralgia, 2015-2025 (US$ Mn)
TABLE 4 Global Trigeminal Neuralgia Treatment Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 5 Allergen Plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 6 Biogen Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 7 Kineta Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments
TABLE 8 Merz Pharma GmbH & Co.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 9 Trigemina Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Development
TABLE 10 Abbot Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 11 Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 12 GlaxoSmithkline Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 13 Novartis : Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 14 Shire : Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)